The differential diagnostic impact of the KLK5 expression levels between the malignant and the benign breast tumors as well as the use of the KLK5 expression analysis for the prediction of breast cancer was also assessed by ROC analysis. The gene discussed is KLK5; the disease is breast carcinoma.